Are glutamate transporters neuroprotective or neurodegenerative during cerebral ischemia?

J Mol Med (Berl). 2019 Mar;97(3):281-289. doi: 10.1007/s00109-019-01745-5. Epub 2019 Jan 23.

Abstract

The accumulation of glutamate (Glu) in the synaptic cleft during cerebral ischemia triggers the death of neurons, causing mental or physical handicap. However, the mechanisms of the alteration in Glu homeostasis and the imbalance between the release and clearance of Glu in ischemia are not yet completely understood. Additionally, the role of Glu transporters in regulating Glu concentration in the synaptic cleft is controversial. This review aims to provide readers with an in-depth understanding of Glu transporters in the early or later stages of ischemic events, or in mild or severe cerebral ischemia via alteration of Glu transporter expression, reversal of Glu transporters function, and trafficking between membrane and cytoplasm, to further clarify whether the Glu transporters are neuroprotective or neurodegenerative during cerebral ischemia. We provide the insights for deeper understanding of the mechanism of Glu transporters regulation after different periods and severities of cerebral ischemia.

Keywords: Cerebral ischemia; Expression; Glutamate transporter; Reversal; Trafficking.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Amino Acid Transport System X-AG / metabolism*
  • Animals
  • Brain Ischemia / metabolism*
  • Humans
  • Neuroprotection
  • Protein Transport

Substances

  • Amino Acid Transport System X-AG